Clinical Practice: WPSI Mammography Screening Recommendation Supported by HRSA and Put into Action

While there is consensus that mammography screening is beneficial for many women, conflicting screening recommendations have led to practice variability. 

In December 2016, the Women’s Preventive Services Initiative (WPSI) multidisciplinary expert coalition developed a new recommendation—Breast Cancer Screening for Average Risk Women. WPSI recommends average-risk women initiate mammography screening no earlier than age 40 and no later than age 50. Screening mammography should occur at least biennially and as frequently as every year. Screening should continue through at least age 74, and age should not be the lone  basis for discontinuing screening.

The Health Resources and Services Administration’s (HRSA) official support of the WPSI breast cancer screening clinical recommendation directs non-grandfathered group health plans and health insurance coverage to screening mammography for women ages 40 and older without cost sharing beginning January 1, 2018. The WPSI recommendation also includes implementation considerations, which recommend that a woman and her provider engage in a shared decision-making process regarding the initiation, duration, and discontinuation of screening mammography. 

The WPSI 2016 report includes the nine recommendations submitted to HRSA and evidence summaries that accompany each recommendation. Download the full 2016 WPSI report for free.

Call for Member and Public Comment on New Topic: Screening for Urinary Incontinence

As part of its recommendation development process, ACOG is soliciting public comment on a new draft recommendation for women's preventive health care services: Screening for Urinary Incontinence

The draft recommendation includes clinical recommendations, implementation considerations, and research recommendations.

The Call for Public Comment closes on October 18, 2017. Visit the WPSI webpage to submit a comment

About WPSI

Through a five-year cooperative agreement with the US Department of Health and HRSA, ACOG has engaged in a multidisciplinary coalition of national health professional organizations and consumer and patient advocates with expertise in women's health across the lifespan to develop, review, and update recommendations for women's preventive health care services. These recommendations on preventive health screenings and services guide clinicians in determining which services they should routinely offer to their patients. The recommendations are based on the best-available evidence and supplemented with expert clinical consensus. The purpose of HRSA’s cooperative agreement with ACOG is to continue the work originally started with the Institute of Medicine (now National Academies of Medicine) to develop women’s preventive services guidelines that acknowledge and adequately serve the unique health needs of women and provide women with more broad access to recommended preventive services.

For more information, please don’t hesitate to contact WPSI staff at wpsi@acog.org or visit www.womenspreventivehealth.org for updates.

 

American Congress of Obstetricians and Gynecologists
409 12th Street SW, Washington, DC  20024-2188 | Mailing Address: PO Box 70620, Washington, DC 20024-9998